Clinical data services provider Discus Analytics has received a US patent for its JointMan software application from the US Patent Office. The company's flagship product, JointMan supports best practices in rheumatologic care, diagnosis ...
Tags: US Patent, Software Application
The US Food and Drug Administration (FDA) has issued Breakthrough Therapy Designation for Catalyst Pharmaceutical Partners’ Firdapse (amifampridine phosphate), which is used to treat patients with Lambert-Eaton Myasthenic Syndrome ...
Tags: Therapy Designation, Medicine
RNAi therapeutics company Alnylam Pharmaceuticals has obtained additional orphan drug designation from US FDA for a RNAi therapeutic, ALN-AT3, to treat hemophilia A. With the additional approval, orphan drug designation for GalNAc ...
Tags: Alnylam, Orphan Drug
IDC forecasts that the IT investment market size of China healthcare industry will reach CNY33.65 billion (US$5.48 billion) in 2017, with a CAGR of 14.5% during 2012-2017. The growth rate in the next five years is expected to be higher than ...
Tags: IT investment market, Healthcare
Regen BioPharma, a wholly owned subsidiary of Bio-Matrix Scientific, has signed a licensing deal with Benitec Biopharma for ddRNAi gene silencing technology to develop vaccines. Regen will apply ddRNAi to silence indoleamine 2,3 -- ...
Tags: Regen BioPharma, Medicine
GP practices could be investigated by the Information Commissioner's Office (ICO) if they fail to warn patients that identifiable data will be extracted from their electronic health records to be used by the National Health Service (NHS) ...
Tags: GPs, EMIS Group software
Castle Biosciences has announced that data from studies of its DecisionDx-Melanoma test confirm previous studies, indicating that the gene expression profile test is a strong predictor for classifying which Stage I or II non-metastatic ...
Cerevast Therapeutics has initiated patient enrollment in the Phase III clinical trial to evaluate the use of its Clotbust ER ultrasonic headframe for the treatment of acute ischemic stroke. The Clotbust ER Phase III clinical study is ...
Tags: Cerevast Therapeutics
GlaxoSmithKline (GSK) and Theravance have withdrawn license application for the use of inhaled drug fluticasone furoate (FF) and vilanterol (VI), with proposed brand name of Relvar Ellipta, as treatment for chronic obstructive pulmonary ...
Tags: Japan, GSK, Relvar License
Accenture has launched a new business service, known as Accelerated R&D Services, to accelerate drug development from discovery to approval to market. Focused on delivering streamlined and integrated research and development (R&D) ...
Tags: Drugs, R&D Service
The federal government is happy to point out that more than 50 percent of physicians and 80 percent of hospitals are using electronic health record (EHR) systems, with those users having received some $14.6 billion in meaningful use ...
Tags: EHR Systems, Computer Products, software
Aptiv Solutions, a US-based medical device and biopharmaceutical company, has introduced AptivInSite, a new adaptive monitoring methodology. Developed for medical device companies, AptivInSite helps in maximising trial efficiency while ...
Tags: Health, Medicine, biopharmaceutical
CryoLife, a US-based tissue processing and medical device company, has secured conditional US FDA approval of its Investigational Device Exemption (IDE) for PerClot. A hemostat made of absorbable polysaccharide granules, PerClot is ...
Tags: Cryolife, Trials of Perclot
Genmab and ADC Therapeutics have partnered to co-develop a new antibody-drug conjugate (ADC) product conjugate to treat multiple cancer indications. The collaboration will integrate Genmab's high-affinity fully human antibody targeting ...
Tags: Genmab, ADC Partner
Integrity Applications, an Israel-based medical device company, has received CE Mark approval for its GlucoTrack DF-F non-invasive device. The GlucoTrack DF-F is a glucose measuring device that uses a patented combination of ultrasound, ...